62 related articles for article (PubMed ID: 10626684)
1. Prognostic significance of autoantibodies against tropomyosin in patients with colorectal adenocarcinoma.
Syrigos KN; Charalampopoulos A; Pliarchopoulou K; Syrigou EI; Avuzuklidou M; Manouras A; Leandros M
Hybridoma; 1999 Dec; 18(6):543-6. PubMed ID: 10626684
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma.
Syrigos KN; Charalambopoulos A; Pliarchopoulou K; Varsamidakis N; Machairas A; Mandrekas D
Anticancer Res; 2000; 20(6B):4351-3. PubMed ID: 11205270
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against cardiolipin in the serum of patients with colorectal adenocarcinoma: their prognostic significance.
Syrigos KN; Charalampopoulos A; Konstantoulakis MM; Karayiannakis A; Tsibloulis V; Peveretos P
Eur Surg Res; 1998; 30(1):55-60. PubMed ID: 9493695
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in the serum of patients with gastric cancer: their prognostic importance.
Konstandoulakis MM; Syrigos KN; Leandros M; Charalabopoulos A; Manouras A; Golematis BC
Hybridoma; 1998 Oct; 17(5):431-5. PubMed ID: 9873988
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of antibodies against tropomyosin, actin and myosin in patients with dilated cardiomyopathy.
Konstadoulakis MM; Kroumbouzou H; Tsiamis E; Trikas A; Toutouzas P
J Clin Lab Immunol; 1993; 40(2):61-7. PubMed ID: 7932629
[TBL] [Abstract][Full Text] [Related]
6. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
[TBL] [Abstract][Full Text] [Related]
7. Alpha tropomyosin as a self-antigen in patients with Behçet's disease.
Mahesh SP; Li Z; Buggage R; Mor F; Cohen IR; Chew EY; Nussenblatt RB
Clin Exp Immunol; 2005 May; 140(2):368-75. PubMed ID: 15807864
[TBL] [Abstract][Full Text] [Related]
8. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
Veingerl B
Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
[TBL] [Abstract][Full Text] [Related]
9. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
Iarŭmov N; Ignatov A; Viiachki I
Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of circulating antibodies against carcinoembryonic antigen (anti-CEA) in patients with colon cancer.
Albanopoulos K; Armakolas A; Konstadoulakis MM; Leandros E; Tsiompanou E; Katsaragakis S; Alexiou D; Androulakis G
Am J Gastroenterol; 2000 Apr; 95(4):1056-61. PubMed ID: 10763959
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of autoantibodies to: myosin, troponin, tropomyosin and myoglobin in patients with circulating triiodothyronine and thyroxine autoantibodies (THAA).
Ruchala M; Kosowicz J; Baumann-Antczak A; Skiba A; Zamyslowska H; Sowinski J
Neuro Endocrinol Lett; 2007 Jun; 28(3):259-66. PubMed ID: 17627259
[TBL] [Abstract][Full Text] [Related]
12. Naturally occurring IgG autoantibodies to platelet cytoskeleton tropomyosin.
Hou M; Stockelberg D; Kutti J; Wadenvik H
Thromb Haemost; 1996 Apr; 75(4):642-7. PubMed ID: 8743193
[TBL] [Abstract][Full Text] [Related]
13. Serum autoantibodies recognizing 5-hydroxymethyl-2'-deoxyuridine, an oxidized DNA base, as biomarkers of cancer risk in women.
Frenkel K; Karkoszka J; Glassman T; Dubin N; Toniolo P; Taioli E; Mooney LA; Kato I
Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):49-57. PubMed ID: 9456243
[TBL] [Abstract][Full Text] [Related]
14. Thyroid autoantibodies and thyroid function in patients with pancreatic adenocarcinoma.
Fyssas I; Syrigos KN; Konstantoulakis MM; Tsibloulis V; Manouras A; Peveretos P; Golematis BC
Acta Oncol; 1997; 36(1):65-8. PubMed ID: 9090969
[TBL] [Abstract][Full Text] [Related]
15. Correlation between auto-antibodies to survivin and MUC1 variable number tandem repeats in colorectal cancer.
Wang YQ; Zhang HH; Liu CL; Xia Q; Wu H; Yu XH; Kong W
Asian Pac J Cancer Prev; 2012; 13(11):5557-62. PubMed ID: 23317217
[TBL] [Abstract][Full Text] [Related]
16. A reverse-ELISA for the detection of TRIM28/KAP1 serum autoantibodies in colorectal cancer patients.
Hector S; Chen H; Kijanka G; Murray F; Prehn JH
Acta Oncol; 2012 Mar; 51(3):394-6. PubMed ID: 22268577
[No Abstract] [Full Text] [Related]
17. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss.
Gross M; Eliashar R; Ben-Yaakov A; Ulmansky R; Elidan J
Audiol Neurootol; 2008; 13(4):231-8. PubMed ID: 18259075
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of p53 autoantibodies after resection of colorectal cancer: relationship to operative curability.
Takeda A; Shimada H; Nakajima K; Imaseki H; Suzuki T; Asano T; Ochiai T; Isono K
Eur J Surg; 2001 Jan; 167(1):50-3. PubMed ID: 11213822
[TBL] [Abstract][Full Text] [Related]
19. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients.
Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K
Hepatogastroenterology; 2003; 50(51):696-9. PubMed ID: 12828063
[TBL] [Abstract][Full Text] [Related]
20. CEA and CA 19-9 as prognostic indexes in colorectal cancer.
Forones NM; Tanaka M
Hepatogastroenterology; 1999; 46(26):905-8. PubMed ID: 10370636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
